Low-dose intravenous esketamine on a depressive catatonia patient with venous thromboembolism: a case report
As a safe and rapid intervention, Esketamine might be a new option for catatonic patients who cannot undergo MECT or fail to respond to conventional treatment. It may be worthy of further research in the future.
Authors
- M Zhang (ORCID: https://orcid.org/0000-0001-9261-7208)
- Yifan Wang (ORCID: https://orcid.org/0000-0001-9966-682X)
- Juan Li (ORCID: https://orcid.org/0000-0003-0170-0466)
- Xiao Ji (ORCID: https://orcid.org/0009-0002-3432-9472)
- Zijun Liu (ORCID: https://orcid.org/0000-0003-3928-0428)
Institutions
- Beijing Anding Hospital (CN)
- Chinese Institute for Brain Research (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-11-06
- DOI
- https://doi.org/10.3389/fpsyt.2025.1688633
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00